Implantable Shock Absorber for Medial Compartment Osteoarthritis

Key Points

• The analysis shows a focus on patient consent for those participating in the medial compartment osteoarthritis treatment.
• Consent was obtained from identifiable patients involved in the publication process, ensuring ethical standards.
• A statement of release was included with the publication, reflecting rigorous protocol adherence to ethical guidelines.
• Highlights the critical importance of patient consent in research, particularly for invasive treatments like implantable devices.

Abstract